Loading...
CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discover...
Saved in:
| Published in: | Trends Cancer |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461962/ https://ncbi.nlm.nih.gov/pubmed/28603775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.05.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|